ESR2 and ESR1 Genes and Their Protein Products Are Differentially Expressed in Various Breast Cancer Cell Lines, and ERβ Agonists Significantly Enhance ERβ-Driven ERE-Luciferase Promoter Activity. The gene discussed is ESR1; the disease is breast carcinoma.